Conex Tablet
NDC Package 54859-702-60

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Conex (dexbrompheniramine maleate, pseudoephedrine hcl) tablets is other Information: Store at controlled room temperature 20 - 25 degree celsius (68 - 77 degree fahrenheit); excursions permitted to 15 - 30 degree celsius ( 59 - 86 degree fahrenheit) [ See USP Controlled Room Temperature] Tamper evident by imprinted heat seal under cap. This formulation utilizes a tablet delivery system. Marketed by Llorens Pharmaceuticals International Division, this product is identified by NDC 54859-702 and is authorized under FDA application M012.

Identification & Billing

NDC Package Code
54859-702-60
Package Description
60 TABLET in 1 BOTTLE
Product Code
54859-702
11-Digit Billing Format
54859070260
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
60 EA
RxNorm Crosswalk
  • RxCUI: 1363513 - dexbrompheniramine maleate 2 MG / pseudoephedrine HCl 60 MG Oral Tablet
  • RxCUI: 1363513 - dexbrompheniramine maleate 2 MG / pseudoephedrine hydrochloride 60 MG Oral Tablet

Clinical Specifications

Proprietary Name
Conex
Non-Proprietary Name
Dexbrompheniramine Maleate, Pseudoephedrine Hcl
Substance Name
Dexbrompheniramine Maleate; Pseudoephedrine Hydrochloride
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Other Information: Store at controlled room temperature 20 - 25 degree celsius (68 - 77 degree fahrenheit); excursions permitted to 15 - 30 degree celsius ( 59 - 86 degree fahrenheit) [ See USP Controlled Room Temperature] Tamper evident by imprinted heat seal under cap. Do not use if there is evidence of tampering.

Regulatory & Marketing

Labeler Name
Llorens Pharmaceuticals International Division
Product Type
Human Otc Drug
FDA Application #
M012
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
11-01-2007
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 54859-702-60 identifies a specific commercial package of 60 tablet in 1 bottle of Conex, a human over the counter drug labeled by Llorens Pharmaceuticals International Division. This product is billed for "EA" each discreet unit and contains an estimated amount of 60 billable units per package. This tablet is formulated for oral use and contains dexbrompheniramine maleate; pseudoephedrine hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Llorens Pharmaceuticals International Division on November 01, 2007. The current certification is valid through December 31, 2026.

How is this Llorens Pharmaceuticals International Division product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 54859070260. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 60 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
54859-702-60
11-Digit CMS (5-4-2)
54859-0702-60

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.